Affimed N.V. (AFMD) Social Stream
Affimed NV (AFMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Affimed NV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 5 | $15 | $10 | $12.2 | $4.4 | 177.27% |
| 2021-11-11 | 5 | $15 | $10 | $12 | $4.4 | 172.73% |
| 2022-01-12 | 5 | $15 | $11 | $12.4 | $4.4 | 181.82% |
| 2022-02-23 | 6 | $12 | $11 | $11.8 | $4.4 | 168.18% |
The Trend in the Analyst Price Target
AFMD's average price target has moved up $6.08 over the prior 21 months.
Over the past 47 weeks, AFMD's average upside potential has been 112.52%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-19 | 5 | 18.21680 | 13.15652 | 15.18047 | 5.54 | 174.02% |
| 2021-08-19 | 5 | 18.09043 | 13.06526 | 15.07516 | 5.54 | 172.11% |
| 2021-09-19 | 5 | 17.84285 | 11.89531 | 14.61645 | 6.39 | 128.74% |
| 2021-09-20 | 5 | 17.61371 | 11.74255 | 14.42875 | 6.30 | 129.03% |
| 2021-09-20 | 5 | 17.73971 | 11.82655 | 14.53196 | 6.30 | 130.67% |
AFMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 153 days, AFMD's average broker recommendation rating improved by 0.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Affimed NV's average analyst price target is greater than 58.57% of all US stocks.
- AFMD has a higher upside potential (average analyst target price relative to current price) than 429.36% of all US stocks.
- AFMD has a lower variance in analysts' estimates than -28.24% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Affimed NV's number of analysts covering the stock is greater than 348.1% of them.
In the Pharmaceutical Products industry, AEZS, ADXS, and ADAG are the three stocks most similar to Affimed NV regarding the price target and analyst recommendation information presented here.
Is AFMD a Buy, Hold or Sell? See the POWR Ratings now!